ULTIVAIR M 50/150/160MCG CAP

ULTIVAIR M is a combination inhalation capsule containing glycopyrronium, indacaterol, and mometasone furoate. This triple-action formulation is designed for maintenance treatment of chronic obstructive pulmonary disease (COPD) in patients requiring multiple therapeutic agents. Glycopyrronium acts as a long-acting muscarinic antagonist to improve airway clearance. Indacaterol, a long-acting beta-2 agonist, provides bronchodilation and enhances airflow. Mometasone furoate, an inhaled corticosteroid, reduces airway inflammation and helps prevent exacerbations. Each capsule delivers 50mcg glycopyrronium, 150mcg indacaterol, and 160mcg mometasone furoate for consistent daily dosing. Suitable for adult patients with moderate to severe COPD who benefit from combined bronchodilator and anti-inflammatory therapy. Use as directed by your healthcare provider. Store in a cool, dry place away from moisture.